CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +26,600 | 54,295 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −2,990 | 2,990 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −9,726 | 9,727 | ||
| 2020-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −26,600 | 53,200 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +2,075 | 45,443 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +1,270 | 46,713 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +4,214 | 50,927 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +8,837 | 59,764 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Shares withheld for taxes | −3,902 | $2.77 | $11K | 55,862 |
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −2,075 | 0 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −1,270 | 1,270 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −4,214 | 4,213 | ||
| 2020-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −8,837 | 17,673 | ||
| 2020-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +2,353 | 21,014 | ||
| 2020-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +2,593 | 23,607 | ||
| 2020-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +8,464 | 32,071 | ||
| 2020-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion | +22,853 | 54,924 | ||
| 2020-02-28 | Santini Alexander A EVP and CCO | Shares withheld for taxes | −12,420 | $2.77 | $34K | 42,504 |
| 2020-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion · Restricted Stock Units | −2,353 | 0 | ||
| 2020-02-28 | Santini Alexander A EVP and CCO | Exercise or conversion · Restricted Stock Units | −2,593 | 2,592 |
Page 35 of 51 · 1,001 trades